Literature DB >> 4594075

Sensitivity of four Central American strains of Plasmodium vivax to primaquine.

L H Miller, D J Wyler, R H Glew, W E Collins, P G Contacos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4594075     DOI： 10.4269/ajtmh.1974.23.309

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  4 in total

Review 1.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

2.  Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.

Authors:  Salomón Durand; Cesar Cabezas; Andres G Lescano; Mariela Galvez; Sonia Gutierrez; Nancy Arrospide; Carlos Alvarez; Meddly L Santolalla; David J Bacon; Paul C F Graf
Journal:  Am J Trop Med Hyg       Date:  2014-04-21       Impact factor: 2.345

3.  Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison.

Authors:  Audrey Valdes; Loic Epelboin; Emilie Mosnier; Gaelle Walter; Guillaume Vesin; Philippe Abboud; Alessia Melzani; Denis Blanchet; Nicaise Blaise; Mathieu Nacher; Magalie Demar; Felix Djossou
Journal:  Malar J       Date:  2018-06-19       Impact factor: 2.979

4.  Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Authors:  Rachael Milligan; André Daher; Patricia M Graves
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.